http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012197230-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d9072cb25d6ae674a3943f14e5771e8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2009-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dead1cc8f04ceeafabe1db5cb03c8ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae67b7936cdea4040dd2b8f2ce96adc6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd92983b0fa038a8334a7241460c5798 |
| publicationDate | 2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012197230-A |
| titleOfInvention | Antitumor agent |
| abstract | To provide a novel and practical antitumor agent that exerts an antitumor effect on a tumor in vivo. An antitumor agent comprising bone morphogenetic protein BMP4 as an active ingredient. The bone morphogenetic protein BMP4 of the present invention comprises the amino acid sequence shown in SEQ ID NO: 1 or 3 in the sequence listing, or a sequence in which one or several amino acids in the amino acid sequence are deleted, added, or substituted, and Mention may be made of bone morphogenetic proteins comprising amino acid sequences having antitumor activity. In the present invention, as an antitumor agent comprising bone morphogenetic protein BMP4 as an active ingredient, it is administered to cancer patients by intraperitoneal injection or the like, and thereby exhibits antitumor activity due to tumor regression effect due to angiogenesis inhibition or the like in vivo. It can be demonstrated. [Selection figure] None |
| priorityDate | 2009-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.